16497699

Diamanti-Kandarakis E

2006

Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.

16497735

Balen AH

2006

Should obese women with polycystic ovary syndrome receive treatment for infertility?

16498370

Hayden BJ

2006

The role of the central nervous system in the pathogenesis of polycystic ovary syndrome.

16498371

Vicino M

2006

[Polycystic ovary syndrome: from physiopathology to therapy].

16500338

Douglas CC

2006

Role of diet in the treatment of polycystic ovary syndrome.

16500361

Vanky E

2006

Beneficial effect of metformin on pregnancy outcome in women with polycystic ovary syndrome is not associated with major changes in C-reactive protein levels or indices of coagulation.

16500371

Yao LQ

2006

Characterization of unilateral polycystic ovary compared with polycystic ovary syndrome.

16501038

Tang T

2006

The use of metformin for women with PCOS undergoing IVF treatment.

16501039

Rautio K

2006

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study.

16503761

Boden G

2006

Recent findings concerning thiazolidinediones in the treatment of diabetes.

16505239

Corbould A

2006

Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome.

16505579

Gogia A

2006

Metabolic syndrome.

16506113

Sherer DM

2006

Hyperreactio luteinalis presenting with marked hyperglycemia and bilateral multicystic adnexal masses at 21 weeks gestation.

16508325

Malouf MA

2006

Cognitive outcome in adult women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

16509054

Dinger Y

2005

DNA damage, DNA susceptibility to oxidation and glutathione level in women with polycystic ovary syndrome.

16510536

Jin L

2006

A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS.

16514202

Sander V

2006

Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone.

16516374

Bokal EV

2006

Follicular sterol composition in gonadotrophin stimulated women with polycystic ovarian syndrome.

16517043

Iatrakis G

2006

Polycystic ovarian syndrome, insulin resistance and thickness of the endometrium.

16519031

Watts J

2006

Understanding the causes and management of hirsutism.

16520442

Bridger T

2006

Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.

16521439

Krysiak R

2005

[Advance in treatment of polycystic ovary syndrome].

16522285

Boudreaux MY

2006

Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.

16522532

Genazzani AD

2006

Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome.

16522691

Xita N

2006

Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies.

16522732

Gonz?lez F

2006

In vitro evidence that hyperglycemia stimulates tumor necrosis factor-alpha release in obese women with polycystic ovary syndrome.

16528092

Laredo SE

2006

Obesity, polycystic ovary syndrome, infertility treatment: asking obese women to lose weight before treatment increases stigmatisation.

16528093

Lord JM

2006

Obesity, polycystic ovary syndrome, infertility treatment: lifestyle modification is paramount.

16529387

Koren G

2006

Metformin use during the first trimester of pregnancy. Is it safe?

16530767

Dehbashi S

2006

Time of initiation of clomiphene citrate and pregnancy rate in polycystic ovarian syndrome.

16531164

Cagnacci A

2006

Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.

16532170

Recabarren SE

2006

[Prenatal exposure to androgens as a factor of fetal programming].

16533167

Guido M

2006

Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.

16533342

Kaibe M

2006

Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population--possible susceptibility of HLA-A11 and -DRB1*0403 to patient population with polycystic ovary syndrome.

16543255

Elnashar A

2006

Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study.

16543679

Iwasa T

2006

Comparison and problems of measured values of LH, FSH, and PRL among measurement systems.

16546480

Diamanti-Kandarakis E

2006

Short-term effect of orlistat on dietary glycotoxins in healthy women and women with polycystic ovary syndrome.

16546482

Glueck CJ

2006

Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.

16549423

Hahn S

2006

Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality.

16551732

Foong SC

2006

Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization.

16551740

Gambineri A

2006

Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.

16552830

Ushiroyama T

2006

Effects of switching to wen-jing-tang (unkei-to) from preceding herbal preparations selected by eight-principle pattern identification on endocrinological status and ovulatory induction in women with polycystic ovary syndrome.

16552990

Starka L

2005

Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?

16556672

Kanaya H

2006

Successful monozygotic twin delivery following in vitro maturation of oocytes retrieved from a woman with polycystic ovary syndrome: case report.

16556719

Yesilada E

2006

Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome.

16564785

Carmina E

2006

Endothelial dysfunction in PCOS: role of obesity and adipose hormones.

16569737

Codner E

2006

Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.

16570705

Jahanfar Sh

2005

Subclinical eating disorder, polycystic ovary syndrome- is there any connection between these two conditions through leptin- a twin study.

16575127

Sharabidze N

2006

Cell adhesion and apoptosis in ovarian stromal hyperplasia and hyperthecosis.

16579997

Khorram O

2006

Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndrome.

16579998

Sepilian VP

2006

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens.

16580356

Li Y

2006

Confocal microscopic analysis of the spindle and chromosome configurations of human oocytes matured in vitro.

16580357

Piquette GN

2006

The in vitro maturation (IVM) of human oocytes for in vitro fertilization (IVF): is it time yet to switch to IVM-IVF?

16580359

Trounson A

2006

Spindle abnormalities in oocytes.

16580386

Duleba AJ

2006

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial.

16580387

Thatcher SS

2006

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.

16580388

Kauffman RP

2006

Hyperinsulinemia and circulating dehydroepiandrosterone sulfate in white and Mexican American women with polycystic ovary syndrome.

16580389

Quezada S

2006

Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome.

16580394

Yoo RY

2006

Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism.

16582867

Carmina E

2006

Metabolic syndrome in polycystic ovary syndrome.

16582868

Palomba S

2006

Ovulation induction in infertile patients with polycystic ovary syndrome.

16595112

P?rez L

2006

[Porphyria cutanea tarda in a dialyzed female patient].

16595221

Mastorakos G

2006

Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.

16595222

Rouzi AA

2006

A randomized controlled trial of the efficacy of rosiglitazone and clomiphene citrate versus metformin and clomiphene citrate in women with clomiphene citrate-resistant polycystic ovary syndrome.

16595223

Batukan C

2006

Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.

16595244

Elnashar A

2006

Letrozole induction of ovulation in women with clomiphene citrate-resistant polycystic ovary syndrome may not depend on the period of infertility, the body mass index, or the luteinizing hormone/follicle-stimulating hormone ratio.

16595248

Kolbus A

2006

A polymorphism of the interleukin 1 receptor antagonist is not associated with polycystic ovary syndrome in Caucasian women.

16595250

Dewailly D

2006

How many of the items in the polycystic ovary syndrome can be validated statistically?

16595251

McDonough PG

2006

How many of the items in the polycystic ovary syndrome can be validated statistically?

16598331

Al-Ojaimi EH

2006

Pregnancy outcomes after laparoscopic ovarian drilling in women with polycystic ovarian syndrome.

16599037

Zafar S

2005

Role of metformin in correcting hyperinsulinemia, menstrual irregularity and anovulation in polycystic ovary syndrome.

16600228

Galli-Tsinopoulou A

2006

Multifollicular ovaries in female adolescents with cystic fibrosis.

16600233

Wang Y

2006

Polymorphisms of the peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha genes in Chinese women with polycystic ovary syndrome.

16600693

Pylv?nen V

2006

Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.

16603055

Lin TC

2006

Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese population- not correlated with insulin receptor substrate-1 Gly972Arg/Ala513Pro polymorphism.

16603432

Coffey S

2006

Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36).

16603436

Tingthanatikul Y

2006

Prevalence and clinical predictors of endometrial hyperplasiain anovulatory women presenting with amenorrhea.

16604826

Atay V

2006

Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation.

16606451

Abbott DH

2006

Contributions of androgen and estrogen to fetal programming of ovarian dysfunction.

16608676

Meurer LN

2006

Clinical inquiries. What is the best way to diagnose polycystic ovarian syndrome?

16612122

van Weissenbruch MM

2006

Early influences on the tempo of puberty.

16612673

Carter JJ

2006

Incidence of acneform reactions after laser hair removal.

16613823

Kousta E

2005

Polycystic ovary syndrome. Revised diagnostic criteria and long-term health consequences.

16614663

Glueck CJ

2005

Response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia.

16616742

Ao A

2006

First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cycle in vitro fertilization combined with an in vitro maturation procedure.

16616745

La Marca A

2006

Serum anti-m?llerian hormone levels in women with secondary amenorrhea.

16620491

Al-Inany H

2005

Polycystic ovary syndrome.

16622288

Puzziferri N

2006

Surgical treatment of obesity.

16630296

Mohan VS

2006

Cleidocranial dysplasia with bilateral polycystic ovarian disease and Mullerian abnormality of the uterus: a case report.

16630737

Reyss AC

2006

[Rotterdam consensus in adolescent girls: which investigations and how to interpret them to make the diagnosis of PCOS?].

16632599

Sam S

2006

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

16634794

Palacio JR

2006

The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients.

16636126

Hickey TE

2006

Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome.

16638037

Johnson NP

2006

No more surrogate end-points in randomised trials: the PCOSMIC trial protocol for women with polycystic ovary syndrome using metformin for infertility with clomiphene.

16638042

Topcu S

2006

Do women with polycystic ovary syndrome really have predisposition to atherosclerosis?

16638044

Chan LY

2006

Re: Effects of rosiglitazone on hormonal profile and ovulatory function in Chinese women with polycystic ovary syndrome.

16638261

Widdowson DC

2006

Polycystic ovary syndrome.

16640883

Zhao JZ

2006

[In vitro maturation and fertilization of unstimulated immature oocyte for the treatment of infertile women].

16641848

Adams Hillard PJ

2006

Adolescent menstrual health.

16641855

Mastorakos G

2006

The hypothalamic-pituitary-adrenal and the hypothalamic- pituitary-gonadal axes interplay.